Scarica l'app Stockscreener
0.8617
80.15%
-3.4983
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Forum
Previsione
Frazionamento azionario
Vistagen Therapeutics Inc Borsa (VTGN) Ultime notizie
Vistagen stock craters after social anxiety study comes up empty - FirstWord Pharma
VistaGen stock rating downgraded by William Blair after trial miss - Investing.com UK
Maxim Downgrades Vistagen Therapeutics to Hold From Buy - marketscreener.com
Stifel downgrades VistaGen stock to Hold as anxiety drug fails in trial - Investing.com
Why Did Vistagen Stock Tank 82% Today? - Stocktwits
Vistagen (VTGN) Faces Setback as Phase 3 Trial Misses Primary En - GuruFocus
Vistagen downgraded to Neutral from Buy at Lucid Capital - TipRanks
Vistagen (VTGN) Phase 3 Study Results for Social Anxiety Treatme - GuruFocus
Vistagen SAD study did not achieve primary endpoint - TipRanks
Vistagen’s anxiety treatment fails to meet primary endpoint in trial - Investing.com
Vistagen’s anxiety treatment fails to meet primary endpoint in trial By Investing.com - Investing.com Canada
Vistagen flunks late-stage trial for social anxiety drug (VTGN) - Seeking Alpha
Vistagen Announces Topline Results From Palisade-3 Phase 3 Study - TradingView — Track All Markets
Social anxiety nose-spray drug stumbles in key trial, but safety holds up - Stock Titan
Vistagen Therapeutics Earnings Notes - Trefis
Fed Meeting: Can Vistagen Therapeutics Inc stock beat analyst upgradesJuly 2025 Review & Low Drawdown Investment Strategies - moha.gov.vn
VistaGen Therapeutics (NASDAQ:VTGN) Share Price Crosses Above 50-Day Moving AverageShould You Sell? - MarketBeat
Would You Still Hold Vistagen Therapeutics Stock If It Fell 30%? - Trefis
Is Vistagen Therapeutics Inc (VTGN) positioned for future growth? - setenews.com
Can Vistagen Therapeutics Stock Recover If Markets Fall? - Trefis
Is Vistagen Therapeutics Stock Built to Withstand More Downside? - Trefis
Why Vistagen Therapeutics Inc. stock is trending among retail tradersJuly 2025 Final Week & Free Community Consensus Stock Picks - Newser
Will Vistagen Therapeutics Inc. stock pay special dividends2025 Year in Review & Reliable Entry Point Trade Alerts - Newser
VistaGen Therapeutics (NASDAQ:VTGN) Stock Price Passes Below 50 Day Moving AverageHere's Why - MarketBeat
VistaGen Therapeutics Appoints New CFO Nick B. Tressler - TipRanks
Vistagen Appoints Nick Tressler as Chief Financial Officer - BioSpace
VistaGen appoints Nick Tressler as CFO - MSN
The time has not yet come to remove your chips from the table: Vistagen Therapeutics Inc (VTGN) - Setenews
Vistagen Therapeutics Appoints Nick Tressler as CFO - marketscreener.com
Vistagen (VTGN) Appoints New CFO, Nick Tressler - GuruFocus
Vistagen (VTGN) Names Nick Tressler as New CFO - GuruFocus
Vistagen Names Nick Tressler as Chief Financial Officer - Contract Pharma
Vistagen appoints Nick Tressler as chief financial officer - marketscreener.com
Vistagen (Nasdaq: VTGN) appoints CFO Nick Tressler, grants 150,000-share option - Stock Titan
Why retail investors pile into Vistagen Therapeutics Inc. stock2025 Sector Review & Technical Pattern Based Signals - BỘ NỘI VỤ
Vistagen Therapeutics Inc. (VTGN) Stock Price | Live Quotes & Charts | NASDAQ - StocksToTrade
Vistagen (VTGN) Presents Promising Data on PH80 for Menopause Sy - GuruFocus
Vistagen presents data on PH80 for menopausal hot flashes treatment By Investing.com - Investing.com Canada
Vistagen Reports Findings on PH80’s Brain and Autonomic Effects in Women with Menopausal Hot Flashes at The Menopause Society 2025 Annual Meeting - Yahoo Finance
Form 8-KCurrent report - ADVFN
Vistagen Reports Fiscal Year 2026 Second Quarter Financial Results and Provides Corporate Update - ADVFN
What analysts say about Vistagen Therapeutics Inc stockTop Performing Stocks & Free ETF and Mutual Fund Comparisons - earlytimes.in
Is Vistagen Therapeutics Inc a good long term investmentTechnical Breakout Signals & High Return Capital Strategies - earlytimes.in
Can Vistagen Therapeutics Inc. stock hit analyst price targetsSwing Trade & Expert Verified Stock Movement Alerts - newser.com
What technical charts say about Vistagen Therapeutics Inc. stockJuly 2025 Intraday Action & AI Forecasted Entry and Exit Points - newser.com
Will Vistagen Therapeutics Inc. stock split attract more investorsJuly 2025 Pullbacks & Expert Verified Movement Alerts - newser.com
ETFs Investing in Vistagen Therapeutics, Inc. Stocks - TradingView
Can Vistagen Therapeutics Inc. stock deliver surprise earnings beatQuarterly Market Review & Long Hold Capital Preservation Plans - newser.com
Will Vistagen Therapeutics Inc. stock deliver shareholder valueQuarterly Market Summary & Stepwise Entry and Exit Trade Signals - newser.com
How Vistagen Therapeutics Inc. stock compares to industry benchmarksQuarterly Market Review & Precise Trade Entry Recommendations - newser.com
Is Vistagen Therapeutics Inc. stock attractive for income investorsGold Moves & AI Driven Stock Movement Reports - newser.com
Is Vistagen Therapeutics Inc. a candidate for recovery play2025 Market Outlook & AI Forecast Swing Trade Picks - newser.com
0.52%
0.24%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):